×
About 27,222 results

ALLMedicine™ Epilepsy Center

Research & Reviews  12,377 results

Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevanc...
https://doi.org/10.1177/0883073821993000
Journal of Child Neurology; Lee HHC, Pearl PL et. al.

Feb 24th, 2021 - Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare inborn metabolic disorder caused by the functional impairment of SSADH (encoded by the ALDH5A1 gene), an enzyme essential for metabolism of the inhibitory neurotransmitter γ-aminobu...

Nonverbal fluency assessed by the five-point test in epilepsy patients with unilateral ...
https://doi.org/10.1080/13854046.2021.1887357
The Clinical Neuropsychologist; Muller LC, Mäder-Joaquim MJ et. al.

Feb 24th, 2021 - To investigate the performance of epilepsy patients diagnosed with unilateral mesial temporal sclerosis (MTS) on a nonverbal fluency measure using the five-point test (FPT). Our secondary aim was to investigate any differences in FPT and verbal fl...

Medication adherence, utilization of healthcare services, and mortality of patients wit...
https://doi.org/10.1016/j.yebeh.2021.107829
Epilepsy & Behavior : E&B; Askarieh A, Morrison I et. al.

Feb 23rd, 2021 - Substance misuse is not uncommonly recognized in people with epilepsy (PWE). Mortality is significantly greater in those with comorbid substance misuse, but it remains unclear whether epilepsy care and management contribute to this. This cohort st...

In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epi...
https://doi.org/10.1371/journal.pntd.0009206
PLoS Neglected Tropical Diseases; Ronse M, Irani J et. al.

Feb 23rd, 2021 - A high prevalence of epilepsy has been observed in several onchocerciasis-endemic villages in the Sanaga River basin, Cameroon. Recent studies suggest that ivermectin, a drug that is distributed annually with the aim of eliminating onchocerciasis,...

Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis.
https://doi.org/10.1016/j.seizure.2021.02.010
Seizure Ilyas-Feldmann M, Prüß H et. al.

Feb 22nd, 2021 - To determine long-term seizure outcome, use of antiseizure medication (ASM) and seizure recurrence risk after its withdrawal in patients with autoimmune encephalitis (AE) due to neuronal surface and GAD antibodies. In patients from a specialized A...

see more →

Guidelines  23 results

Practice guideline update summary: Efficacy and tolerability of the new antiepileptic d...
https://doi.org/10.1212/WNL.0000000000005756
Neurology Kanner AM, Ashman E et. al.

Jun 14th, 2018 - To update the 2004 American Academy of Neurology guideline for managing treatment-resistant (TR) epilepsy with second- and third-generation antiepileptic drugs (AEDs). 2004 criteria were used to systemically review literature (January 2003 to Nove...

Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and ris...
https://doi.org/10.1212/WNL.0000000000003685
Neurology Harden C, Tomson T et. al.

Apr 25th, 2017 - To determine the incidence rates of sudden unexpected death in epilepsy (SUDEP) in different epilepsy populations and address the question of whether risk factors for SUDEP have been identified. Systematic review of evidence; modified Grading Reco...

Cavernoma-related epilepsy: review and recommendations for management--report of the Su...
https://doi.org/10.1111/epi.12402
Epilepsia Rosenow F, Alonso-Vanegas MA et. al.

Oct 18th, 2013 - Cerebral cavernous malformations (CCMs) are well-defined, mostly singular lesions present in 0.4-0.9% of the population. Epileptic seizures are the most frequent symptom in patients with CCMs and have a great impact on social function and quality ...

Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsy: Repo...
https://www.aesnet.org/sites/default/files/file_attach/Guidelines/Neurology-2013-Morris-1453-9.pdf
George L. Morris III

Aug 27th, 2013 - VNS may be considered for seizures in children, for LGS-associated seizures, and for improving mood in adults with epilepsy (Level C). VNS may be considered to have improved efficacy over time (Level C).

Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review)...
https://doi.org/10.1111/j.1528-1167.2009.02129.x
Epilepsia Harden CL, Meador KJ et. al.

Jun 9th, 2009 - A committee assembled by the American Academy of Neurology (AAN) reassessed the evidence related to the care of women with epilepsy (WWE) during pregnancy, including antiepileptic drug (AED) teratogenicity and adverse perinatal outcomes. It is hig...

see more →

Drugs  957 results see all →

Clinicaltrials.gov  13,527 results

Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevanc...
https://doi.org/10.1177/0883073821993000
Journal of Child Neurology; Lee HHC, Pearl PL et. al.

Feb 24th, 2021 - Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare inborn metabolic disorder caused by the functional impairment of SSADH (encoded by the ALDH5A1 gene), an enzyme essential for metabolism of the inhibitory neurotransmitter γ-aminobu...

Nonverbal fluency assessed by the five-point test in epilepsy patients with unilateral ...
https://doi.org/10.1080/13854046.2021.1887357
The Clinical Neuropsychologist; Muller LC, Mäder-Joaquim MJ et. al.

Feb 24th, 2021 - To investigate the performance of epilepsy patients diagnosed with unilateral mesial temporal sclerosis (MTS) on a nonverbal fluency measure using the five-point test (FPT). Our secondary aim was to investigate any differences in FPT and verbal fl...

Medication adherence, utilization of healthcare services, and mortality of patients wit...
https://doi.org/10.1016/j.yebeh.2021.107829
Epilepsy & Behavior : E&B; Askarieh A, Morrison I et. al.

Feb 23rd, 2021 - Substance misuse is not uncommonly recognized in people with epilepsy (PWE). Mortality is significantly greater in those with comorbid substance misuse, but it remains unclear whether epilepsy care and management contribute to this. This cohort st...

In pursuit of a cure: The plural therapeutic landscape of onchocerciasis-associated epi...
https://doi.org/10.1371/journal.pntd.0009206
PLoS Neglected Tropical Diseases; Ronse M, Irani J et. al.

Feb 23rd, 2021 - A high prevalence of epilepsy has been observed in several onchocerciasis-endemic villages in the Sanaga River basin, Cameroon. Recent studies suggest that ivermectin, a drug that is distributed annually with the aim of eliminating onchocerciasis,...

Epilepsy - Care at Mayo Clinic - Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/epilepsy/care-at-mayo-clinic/mac-20350102

Feb 23rd, 2021 - Epilepsy care at Mayo Clinic Your Mayo Clinic care team Teamwork Mayo Clinic experts in epilepsy care work together to provide individualized care to each patient. Mayo Clinic's world-renowned epilepsy teams include neurologists, neurosurgeons, im...

see more →

News  309 results

Task Force Tackles FDA Lamotrigine Cardiac Risk Warning
https://www.medscape.com/viewarticle/946270

Feb 21st, 2021 - A joint task force of the American Epilepsy Society (AES) and International League Against Epilepsy (ILAE) has issued an advisory to address concerns arising from a Food and Drug Administration (FDA) warning of cardiac risk in patients taking the ...

COVID-19's Global Impact on Epilepsy
https://www.medscape.com/viewarticle/943001

Dec 20th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Around the globe, the COVID-19 pandemic has placed an enormous strain on patients with epilepsy, new research shows. The pandemic also appears to ...

SUDEP May Explain 3% of All Sudden Deaths in Kids
https://www.medscape.com/viewarticle/942139

Dec 6th, 2020 - Sudden unexpected death in epilepsy (SUDEP) may explain 3% of all sudden deaths in children – a prevalence rate that is at least three times greater than previously reported estimates – new research shows Dr Vicky Whittemore Just a few years ago, ...

Why Are Cases of SUDEP Declining?
https://www.medscape.com/viewarticle/937275

Sep 22nd, 2020 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner. Today I have a special guest, Dr Daniel Friedman, professor of neurology at New York University medical school and the author of a paper ...

Why Are Cases of SUDEP Declining?
https://www.staging.medscape.com/viewarticle/937275

Sep 22nd, 2020 - This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner. Today I have a special guest, Dr Daniel Friedman, professor of neurology at New York University medical school and the author of a paper ...

see more →

Patient Education  29 results see all →